After administration of alloxan (150 mg/kg) to induce diabetes, the rats showed a noticeable increase in levels of total cholesterol (TC), triglycerides (TG), LDL cholesterol, and the liver function biomarker ALT, along with a reduction in HDL cholesterol levels in comparison to untreated controls (Group I). This evidence concerns the gene GPT and diabetes mellitus.